#cardiovascular event

[megasimranmishra]

New study finds new “polypill” drug that can lower heart diseases

New study finds new “polypill” drug that can lower heart diseases

A three-drug medication now called as “polypill” has been developed by theSpanish National Center for Cardiovascular Research (CNIC) and Ferrerwhich was announced on August 26th at the European Society of CardiologyCongress (ESC 2022) held in Barcelona, Spain this year. This miraculousdrug can reduce cardiovascular mortality by upto 33% in patients and preventsecondary cardiovascular events in…

View On WordPress

[newshourbd]

#Aspirin discontinuation tied to increased risk for #Cardiovascularevents News Hour: Adults taking low-dose aspirin — whether to prevent recurrent cardiovascular events or to prevent the first event — face an increased risk for CV events if they stop treatment, finds an observational study in Circulation.

[newshourbd]

Tresiba® demonstrated no increased risk of major cardiovascular events

#Tresiba® demonstrated no increased risk of major #cardiovascular events @NEJM #hypoglycemia

News Hour:

Tresiba® demonstrated no increased risk of major cardiovascular (CV) events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial.

DEVOTE is a long-term, a multinational, randomized, double-blind and event-driven trial conducted to confirm the CV safety of Tresiba® (insulin degludec) compared to insulin glargine U100. In the…

View On WordPress